The demand for GLP-1 therapies is building, not just for diabetes but also for weight management
Many GLP-1 users report hollow cheeks, jowls, crepey necks, and loose skin on the abdomen, arms, and thighs
The Newcastle-Ottawa Scale (NOS) was used for quality assessment, as observational studies were included [20]
(5) coupling Fmoc-AEEA-OH according to the side chain structure of semaglutide, then removing Fmoc protecting groups, and then sequentially coupling Fmoc-AEEA-OH, Fmoc-Glu-OtBu and octadecanedioic acid mono-tert-butyl ester
If there is more evidence that emerges by next year this could alter the cost-effectiveness profile favorably for the obesity drugs
This contributes to feelings of fullness but can also disrupt normal digestion